Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Enlivex Therapeutics Ltd ENLV

Healthcare Biotechnology
Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages... see more

Current News (NDAQ:ENLV)

Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025

GlobeNewswire October 28, 2025

D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex's Knee Osteoarthritis Program

GlobeNewswire September 29, 2025

Enlivex CEO Issues Letter to Shareholders Outlining Strategic Roadmap Following Positive Phase IIa Allocetra(TM) Results

GlobeNewswire September 11, 2025

Enlivex Announces Issuance of New Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

GlobeNewswire September 9, 2025

Enlivex Announces Positive Topline Data From Multi-Country, Randomized, Controlled, Phase I/II Trial Evaluating Allocetra in Patients With Moderate-To-Severe Knee Osteoarthritis

GlobeNewswire August 18, 2025

Enlivex to Present 3-Month Topline Data from Phase IIa Moderate/Severe Knee Osteoarthritis Trial on August 18 Webinar

GlobeNewswire August 14, 2025

Enlivex Reaffirms August 18, 2025 As Target Date For Announcement of Phase II Topline Data

GlobeNewswire July 28, 2025

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology

GlobeNewswire June 10, 2025

Enlivex Selected to Present at Israeli BioMed 2025 Conference

GlobeNewswire May 20, 2025
View More News ››

Opinion & Analysis (NDAQ:ENLV)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ENLV)

BUY BUY BUY BUY BUY

Whytestock is right on the news this thing alocentra gonna be first and only fda approuved
Nibinator - June 26, 2024

H.C. Wainwright Article on Enlivex

Worth the read for investors and potential investors, https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-a-buy-rating-on-enlivex...
HariboSpeedPeak - July 21, 2022

Price Target $15

Bio Blast Pharma Ltd (NASDAQ:ORPN) had its "buy" rating reaffirmed by analysts at Roth Capital (     ). They now have...
Twistedsteel74 - June 13, 2016

Anyone else out there on these?

Looks to be some good movement upwards here, guessing must be some news coming as financials weren't stellar.
Twistedsteel74 - May 26, 2016

Good Entry point here

Picked up some more, should see some finacials any day now according to the market beat email. Should be about due for some updates soon...
Twistedsteel74 - May 19, 2016

Blood bath

Followed by a huge bath, wow alot of investors took a hit off this one, myself included. Sad how the company handled the chain of news...
Twistedsteel74 - March 18, 2016
View more Bullboard ››

Group Eleven Resources Corp.

Group Eleven Resources Corp.

Group Eleven Resources Corp. is a mineral exploration company focused on its Ballywire zinc-lead-silver discovery in Ireland. ...
View More »